Cascadian Therapeutics Inc (CASC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2011 | 06-2011 | 03-2011 | 12-2010 | 09-2010 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -31,152 | -41,089 | -7,116 | -15,618 | -9,464 |
| Depreciation Amortization | 452 | 298 | 127 | 462 | 350 |
| Accounts receivable | N/A | N/A | N/A | -58 | N/A |
| Accounts payable and accrued liabilities | -159 | 15 | 315 | -2 | -21 |
| Other Working Capital | 651 | 1,100 | 800 | -980 | -547 |
| Other Operating Activity | 13,699 | 29,863 | 1,258 | -1,509 | -3,601 |
| Operating Cash Flow | $-16,509 | $-9,813 | $-4,616 | $-17,705 | $-13,283 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -27,794 | 7,477 | 5,323 | -9,119 | -2,679 |
| PPE Investments | -76 | -65 | -46 | -324 | -175 |
| Investing Cash Flow | $-27,870 | $7,412 | $5,277 | $-9,443 | $-2,854 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 45,061 | 43,119 | 29 | 13,688 | 13,645 |
| Other Financing Activity | 4,804 | 4,804 | 4,804 | 0 | 0 |
| Financing Cash Flow | $49,865 | $47,923 | $4,833 | $13,688 | $13,645 |
| Beginning Cash Position | 5,514 | 5,514 | 5,514 | 18,974 | 18,974 |
| End Cash Position | 11,000 | 51,036 | 11,008 | 5,514 | 16,482 |
| Net Cash Flow | $5,486 | $45,522 | $5,494 | $-13,460 | $-2,492 |
| Free Cash Flow | |||||
| Operating Cash Flow | -16,509 | -9,813 | -4,616 | -17,705 | -13,283 |
| Capital Expenditure | -76 | -65 | -46 | -324 | -175 |
| Free Cash Flow | -16,585 | -9,878 | -4,662 | -18,029 | -13,458 |